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Putative epithelial stem cells were identified in the hair follicle bulge as quiescent ‘‘label retaining cells’’. The
study of these cells was hindered until the identification of bulge cell molecular markers, such as CD34
expression and K15 promoter activity. This allowed for the isolation and characterization of bulge cells from
mouse follicles. Bulge cells possess stem cell characteristics, including multipotency, high proliferative
potential, and their cardinal feature of quiescence. Lineage analysis demonstrated that all epithelial layers
within the adult follicle and hair originated from bulge cells. Bulge cells only contribute to the epidermis during
wound healing, but after isolation, when combined with neonatal dermal cells, they regenerate new hair
follicles, epidermis, and sebaceous glands. Bulge cells maintain their stem cell characteristics after propagation
in vitro, thus ultimately they may be useful for tissue engineering applications. Understanding the signals
important for directing movement and differentiation of bulge cells into different lineages will be important for
developing treatments based on stem cells as well as clarifying their role in skin disease.
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Introduction
The field of epithelial stem cells is
progressing rapidly largely because of
technical advances in molecular and
cellular biology. Many astute observa-
tions over the last century led to
predictions about epithelial stem cells
that only recently have been defini-
tively addressed through new techni-
ques. Here, I review the evolution of
current thinking on epithelial stem
cells, concentrating on those found in
the hair follicle, and delineate future
challenges for applying our knowledge
to reap clinical benefits.
What are epithelial stem cells?
Self-renewing tissues, such as the epi-
dermis and hair follicle, continuously
generate new cells to replenish the
dead squames and hairs, which are
sloughed into the environment. There-
fore, perhaps the simplest definition of
an epithelial stem cell is based on
lineage: a stem cell is the cell of origin
for terminally differentiated cells in
adult tissues. For example, tracing the
lineage of a corneocyte or hair cell
back to its ultimate source in the adult
skin leads to a stem cell. However,
because the tools required to perform
lineage analysis have not been avail-
able until recently, investigators have
principally adopted definitions from
the hematopoietic system. In particular,
stem cells were felt to be self-renewing,
multipotent, and clonogenic, similar to
stem cells in the hematopoietic system
that can regenerate all of the blood
lineages from one cell after transplant-
ation. In contrast to the hematopoietic
stem cell field, cutaneous epithelial
stem cell biologists also relied heavily
on quiescence as a major stem cell
characteristic. This can be attributed to
the pioneering work of Bickenbach and
Mackenzie, who devised ‘‘label-retain-
ing cell’’ methods for detecting quies-
cent cells in the epidermis (Bickenbach
and Mackenzie, 1984), and Morris
et al. (1986) who showed that these
cells retained carcinogen and pos-
sessed proliferative characteristics of
stem cells.
Localization of epithelial stem cells
With respect to the epidermis (which in
this review refers to the interfollicular
epidermis), we know that cells are
generated through proliferation that
occurs only in the basal layer; there-
fore, stem cells must be located there.
Within the basal layer, however, kera-
tinocytes display heterogeneous prolif-
erative characteristics. In mouse skin,
individual basal cells divide less fre-
quently compared to their surrounding
cells. The slower cycling central cell
and more rapidly proliferating sur-
rounding cells constitute approximately
10 basal cells and are roughly orga-
nized into a hexagonal unit, which lies
beneath a single squame (Mackenzie,
1970). Based on these proliferative and
morphological characteristics, Potten
(1974) coined the term ‘‘epidermal
proliferative unit’’ (EPU) to describe
this architecture. Without the benefit of
direct lineage analysis, it was assumed
that the central cell within the EPU
generates the rapidly proliferating cells,
termed transient or transit amplifying
(TA) cells, which move laterally and
then differentiate and move upward
(see article by Kaur, on page 1450).
Thus, within the epidermis, the main
source of cells, that is the stem cells,
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responsible for continual epidermal
renewal appear to reside in the center
of the EPU, and testing of this concept
in unmanipulated pelage epidermis of
the mouse supports this view (Ito et al.,
2005).
Similar to the epidermis, the hair
follicle generates a terminally differen-
tiated keratinized end product, the hair
shaft, that is eventually shed. Tracing
back a hair shaft cell to its origin in
adult skin is not straightforward. In
contrast to epidermis, the follicle un-
dergoes cyclical regeneration, and has
a more complicated proliferative pro-
file and architecture with at least eight
different epithelial lineages (Figure 1).
Hair is formed by rapidly proliferat-
ing matrix keratinocytes in the bulb
located at the base of the growing
(anagen) follicle. The duration of ana-
gen varies drastically between hairs of
differing lengths. For example, mouse
hair follicles and human eyebrow hair
follicles stay in anagen for only 2–4
weeks while scalp follicles can remain
in anagen for many years. Neverthe-
less, matrix cells eventually stop pro-
liferating, and hair growth ceases at
catagen when the lower follicle re-
gresses to reach a stage of rest (telogen).
After telogen, the lower hair-producing
portion of the follicle regenerates,
marking the new anagen phase. Gen-
erally, in parallel to anagen onset in
humans, the hair shaft is shed during
the exogen stage (Milner et al., 2002).
As the lower portion of the follicle
cyclically regenerates, hair follicle stem
cells were thought to govern this
growth. Historically, hair follicle stem
cells were assumed to reside exclu-
sively in the ‘‘secondary germ’’
(Figure 2), which is located at the base
of the telogen hair follicle. It was felt
that the secondary germ moved down-
ward to the hair bulb during anagen
and provided new cells for production
of the hair. At the end of anagen, the
secondary germ was thought to move
upward with the dermal papilla during
catagen to come to rest at the base of
the telogen follicle. This scenario of
stem cell movement during follicle
cycling was brought into question
when we identified a population of
long-lived presumptive stem cells,
using label retaining cell methods, in
an area of the follicle surrounding the
telogen club hair, and not in the hair
bulb (Cotsarelis et al., 1990). That the
presumptive stem cells localized to a
previously defined area called the
bulge was not appreciated until I read
a description of the human embryonic
follicle by Pinkus (1958)
This bulge, often the most conspi-
cuous detail of the young germ, is as
large as the bulby. The function of
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Figure 1. Hair follicle cycle and anatomy. The hair follicle cycle consists of stages of rest (telogen), hair
growth (anagen), follicle regression (catagen), and hair shedding (exogen). The entire lower epithelial
structure is formed during anagen, and regresses during catagen. The transient portion of the follicle
consists of matrix cells in the bulb that generate seven different cell lineages, three in the hair shaft, and
four in the inner root sheath (IRS). Abbreviations: B, bulge; DP, dermal papilla; H, hair; IRS, inner root
sheath; M, matrix; ORS, outer root sheath; S, sebaceous gland; Sec Grm, secondary germ.
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Figure 2. Location of hair follicle stem cells: two models. In one view, the ‘‘secondary germ cells’’,
named for their similarity to primary germ cells present during development, were thought to contain the
stem cells for the follicle. It was assumed that these cells migrated from the base of the telogen follicle to
the bulb during anagen onset, and then migrated back up during catagen. To date, no direct evidence
(e.g. label retaining cell studies or lineage analysis) has been presented that any epithelial cells in the
bulb survive during catagen. The secondary germ cells found at the base of the telogen follicle appear to
arise from the lowermost portion of the bulge at the end of catagen (Ito et al., 2004). Based on
morphology, the telogen secondary germ generates the new hair and inner root sheath (IRS), although this
needs to be addressed experimentally. The origin and fate of the matrix keratinocytes in the bulb, which
possess an undifferentiated phenotype is an area worthy of exploration. It is not known whether bulge
cells migrate down the follicle during anagen to continuously supply the matrix cells with new cells, or
whether the matrix cells self-renew throughout anagen. Abbreviations: B, bulge; DP, dermal papilla; IRS,
inner root sheath; Sec Grm, secondary germ.
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the bulge is obscure. While it serves
as the point of insertion of the
arrector muscle later in life, it
develops much earlier than the
muscle and the latter seems to
originate quite independently in the
skin near the sebaceous gland, and
in many instances streaks by the
bulge before approaching the lower
follicle below it. Unna (1876)
named the bulge area of the adult
follicle the hair bed (Haarbett) be-
lieving that the club hair became
implanted there and derived addi-
tional growth from it. Sto¨hr gave it
the neutral name ‘‘Wulst’’ (bulge or
swelling). Some texts state that this is
an area of marked proliferative
activity, but no mitotic figures were
observed in the bulge even if other
parts of the follicle contained them.
Whatever its function, the bulge
marks the lower end of the ‘‘perma-
nent follicle’’ later in life. Everything
below it is expendable during the
hair change (cycle)’’.
This remarkable description, based
purely on morphological observations,
portended the characterization of the
bulge cells in both human and mouse
follicles as an area containing quies-
cent cells important for hair follicle
cycling (Cotsarelis et al., 1990; Lyle
et al., 1998; Taylor et al., 2000;
Oshima et al., 2001; Morris et al.,
2004). In the mouse pelage follicle, the
area analogous to the human bulge
becomes morphologically apparent in
the postnatal period during the first
telogen stage at the site of arrector pili
muscle attachment. The shape of the
bulge in the mouse follicle results from
displacement of the outer root sheath
(ORS) by the club hair. In the human
follicle, the bulge appears as a true
thickening of the ORS, but generally
becomes much less apparent with age
(Figure 3).
The lack of markers for bulge cells
hindered the study of this area. To date,
probably the best (most specific) mar-
ker for mouse hair follicle bulge cells is
CD34 expression as first defined by
Trempus et al. (2003). CD34, which
interestingly is also a hematopoietic
stem cell marker in the human, but not
the mouse, highlights the bulge cells
specifically within the cutaneous
epithelium. Although it is also ex-
pressed by cells in the dermis, it is a
cell surface protein, and antibodies
recognizing CD34 were used to collect
viable bulge cells by fluorescent acti-
vated cell sorting (Trempus et al., 2003;
Blanpain et al., 2004). Keratin 15
expression in human bulge cells was
first described by Lyle et al. (1998)
(Figure 3). K15 mRNA and protein are
reliably expressed at high levels in the
bulge, but lower levels of expression
can be present in the basal layers of the
lower follicle ORS and the epidermis,
thus the use of K15 expression as the
sole criterion for defining a bulge cell
is not advisable (Lyle et al., 1998;
Waseem et al., 1999). K15 expression
in the epidermis is prominent in neonatal
mouse and human skin but decreases
with age (Liu et al., 2003; Webb et al.,
2004). However, a K15 promoter used
for generation of transgenic mice pos-
sesses a pattern of activity restricted to
the bulge in the adult mouse (Liu et al.,
2003). This proved to be a powerful
tool for studying bulge cells, and will
be discussed below.
A salient feature of the bulge cells is
their quiescence. In both adult mouse
and human skin grafted to immuno-
deficient mice, the administration of
nucleoside analogs, such as tritiated
thymidine or bromodeoxyuridine,
which are taken up by cells in S-phase,
does not result in labeling of the bulge
cells except at anagen onset (Ito et al.,
2002, 2004). Once labeled as either
neonates or during anagen onset, when
stem cells are proliferating, bulge cells
can remain labeled for 14 months in
the mouse (Morris and Potten, 1999)
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Figure 3. Human bulge cell morphology and markers. (a) The bulge is a prominent structure in fetal skin,
but (b) generally is not morphologically distinct in the adult. (c) Immunostaining for K15 expression in
scalp preferentially detects bulge cells. (d) Although CD34 is an excellent marker for mouse bulge
cells, in human scalp, CD34 is not expressed by bulge cells, which do express K15, as shown in this
telogen follicle. (e) CD34 is expressed by a population of cells in the lower outer root sheath (ORS) of the
human anagen follicle. The staining patterns for K15 and CD34, which include a double-positive cell
population (e, right middle panel), suggest that CD34-positive cells may be immediate descendents of
K15-positive stem cells in the bulge. (magnification, (a, b, d, e):  200, (c): 20).
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and at least 4 months (the longest
period examined) in the human (Lyle
et al., 1998). This prolonged quies-
cence is remarkable given that the
surrounding cells proliferate at a much
higher rate, and suggests that bulge
cells persist for the lifetime of the
animal.
Once the bulge cells were identified
as presumptive epithelial stem cells
based on their ability to retain label, it
was necessary to evaluate whether
these cells possessed other expected
characteristics important for stem cells.
In particular, did they exhibit a high
proliferative potential? Were they mul-
tipotent, generating all epithelial cell
types within the follicle, as well as
epidermis and sebaceous gland? Did
they have a ‘‘molecular signature of
stemness’’ shared with other stem cell
populations? These questions were im-
portant not only from a biological
perspective but also from a therapeutic
one. A better understanding of the role
of bulge cells in renewal of the
epithelium should provide insights into
wound healing, gene therapy, aging,
and carcinogenesis.
In vitro assessment of proliferative
potential
As stem cells are responsible for con-
tinual renewal of the tissue, they should
possess a high proliferative capacity. In
keratinocytes, this proliferative capabi-
lity can be assayed in vitro by examin-
ing the clonogenicity of individual cells
through serial passage. Approximately
5% of adult epidermal basal cells
possess a ‘‘holoclone’’ phenotype charac-
terized by high reproductive capacity
and low level of terminal differentia-
tion, and these cells are thought to
represent stem cells (Barrandon and
Green, 1987). Another indicator of
proliferative capability is colony-form-
ing efficiency (CFE; colonies per num-
ber of cells plated) that is thought to
correlate to the number of stem cells in
a tissue (Jones and Watt, 1993; Ko-
bayashi et al., 1993). These types of
analyses revealed that the epidermis
possesses three major types of cells
with respect to their proliferative capa-
city. Terminally differentiated cells
have no proliferative capacity, TA
cells have a limited capacity (forming
abortive small colonies) and epidermal
stem cells have clonogenic capacity
(Jones and Watt, 1993; Jones et al.,
1995). For the epidermis, the number
of colony-forming units is likely repre-
sentative of the stem cell population,
although direct proof, through lineage
analysis, that all central cells within the
EPU are holoclones is lacking.
Similar analyses have also been
applied to the hair follicle epithelium
with mixed and sometimes contradic-
tory results. In rat vibrissae, CFE analy-
sis localizes the large majority (495%)
of clonogenic cells to the hair follicle
bulge (Kobayashi et al., 1993). How-
ever, in human hair follicles, CFE was
reported greatest outside of the bulge
region, in the lower ORS (Rochat et al.,
1994). This was surprising since this
portion of the follicle undergoes degene-
ration during catagen, and these data
are not in line with in vivo, label-
retaining studies that localize LRC to
the human hair follicle bulge (Lyle
et al., 1998). Possible explanations for
the culture results are that current
culture conditions actually support
propagation of TA cells in addition to
hair follicle stem cells or that culturing
keratinocytes leads to ‘‘reprogram-
ming’’ events that overestimates the
number of true stem cells within a
tissue.
Some of the discrepancies are ex-
plained by studies on vibrissa follicles,
which show that the stage of the follicle
at the time of isolation influences how
well cells grow in culture (Oshima
et al., 2001). Since human hair follicles
are not synchronized in their growth
relative to one another, and since the
anagen stage in human follicles lasts for
many years, each isolated anagen
follicle that was analyzed for CFE may
have yielded very different results
(Rochat et al., 1994). For example, a
follicle that has been in anagen for only
1 month might produce a greater
number of colonies from the bulge
compared to one in anagen for 6 years,
which may have more colonies from
lower portions of the follicle.
Other types of in vitro studies based
on epithelial outgrowths from ex-
planted follicles have also produced
conflicting results. Whole follicle ex-
plant cultures give rise to epithelial
growths from the ORS (Yang et al.,
1993; Moll, 1996). In one study, the
outgrowths were seen in the area
believed to represent the bulge of
human hair follicles (Yang et al.,
1993). In another, many outgrowths
were seen in the upper central ORS,
which was believed to be lower than
the bulge, but which likely includes the
lower portion of what is the bulge
(Moll, 1996). Again, these differences
may be related to the heterogeneity of
anagen in human follicles, or simply to
the inability to recognize the bulge in
adult follicles. More recently, however,
Roh et al. (2005) decreased the influ-
ence of the hair follicle cycle by
concentrating on telogen follicles,
which possess a well-defined bulge
area. They demonstrated major differ-
ences in vitro between bulge cells
isolated from telogen follicles and bulb
cells isolated from anagen follicles. The
bulge cells possessed a higher prolif-
erative potential than the bulb cells,
which possessed a very mobile pheno-
type demonstrated by time lapse photo-
graphy (bulb keratinocytes migrated
0.7 mm/min compared to 0.1 mm/min
for bulge cells). These data support the
idea that bulb keratinocytes are TA
cells and possess a finite proliferative
potential. This concept was originally
proposed as an explanation for why
anagen follicles eventually enter cata-
gen (Cotsarelis et al., 1990), although
this needs further testing.
To complicate matters, recent data
using CFE and holoclone analysis
remain somewhat mixed, although
most of the data support the idea that
the bulge cells possess a high prolife-
rative potential. Isolated bulge cells
grown on feeder cells in vitro formed
more numerous colonies than non-
bulge keratinocytes (Trempus et al.,
2003). Morris et al. (2004) showed that
isolated bulge cells formed larger and
more numerous colonies than non-
bulge basal keratinocytes. Blanpain
et al. (2004) reported that the large
majority of holoclones originate from
the bulge in the adult mouse, while
basal epidermis did not form any
holoclones, although both of these
populations had similar CFE. Given
that similar culture conditions were
used for all three studies, these findings
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may reflect the inherent variability and
difficulty in interpreting in vitro prolife-
ration studies (Joseph and Morrison,
2005). Furthermore, since the bulge
cells are enriched for stem cells, while
the basal epidermis to which bulge
cells are compared, possesses stem, TA,
and even differentiated cells, one
would expect a higher percentage of
holoclones from the bulge. Thus, the
utility of this type of analysis seems
limited.
Multipotent bulge cells?
If the stem cells of the hair follicle are
located in the bulge, then these cells
should give rise to all of the lower hair
follicle epithelial cell types. Early evi-
dence supporting the concept that
bulge cells generate the lower follicle
includes proliferation studies showing
that bulge cells preferentially prolife-
rate at anagen onset (Wilson et al.,
1994; Ito et al., 2004). More convin-
cing evidence suggesting that bulge
cells are the origin of the lower follicle
arose from in vivo labeling studies and
transplantation studies. Taylor used a
double-labeling technique to trace the
progeny of bulge cells in intact pelage
follicles (Taylor et al., 2000). Faint
labeling evident as a ‘‘speckled’’ pat-
tern was found in some cells of the
lower follicle, suggesting that these
cells had indeed originated in the
bulge. Similarly, Tumbar et al. (2004)
used persistence of GFP label as an
indication that lower epithelial cells
were progeny of the bulge cells.
Neither study provided convincing
evidence that all hair matrix keratino-
cytes in the bulb originated from bulge
cells, and both suffered from inability
to permanently mark bulge cells and
their progeny. Oshima et al. took a
different approach and transplanted
bulge regions from vibrissa follicles
isolated by dissection from ROSA26
mice into non-ROSA follicles that were
then grafted under the kidney capsule
of an immunocompromised mouse.
ROSA26 mice express lacZ under the
control of the ubiquitous ROSA pro-
moter, thus the fate of the transplanted
cells could be followed. After several
weeks, the labeled bulge cells had
migrated down the vibrissa follicle
and at later time points, some follicles
expressed lacZ in all epithelial cell
layers of the lower follicle. These
elegant studies were limited because
of the unclear starting cell population,
the manipulation performed during
grafting, and the use of vibrissa folli-
cles, which are markedly different than
other mouse and human follicles.
More definitive evidence for bulge
cell multipotency in vivo was reported
using the K15 promoter to target these
cells with an inducible Cre (CrePR1)
construct. CrePR1 is a fusion protein
consisting of Cre-recombinase and a
truncated progesterone receptor that
binds the progesterone antagonist,
RU486 (Berton et al., 2000). In K15-
CrePR1 transgenic mice, CrePR1
remains inactive in the cytoplasm of
the K15-positive cells except during
RU486 treatment, which permits
CrePR1 to enter the nucleus and
catalyze recombination. K15-CrePR1
mice were crossed with R26R reporter
mice that express LacZ under the
control of the ubiquitous ROSA26
promoter after Cre-mediated removal
of an inactivating sequence. Transient
treatment of adult K15-CrePR1;R26R
mice with RU486 results in permanent
expression of LacZ in the bulge cells
and in all progeny of the labeled bulge
cells (Morris et al., 2004). From this
approach, it is clear that cells originat-
ing in the bulge generated all epithelial
cell types in the lower hair follicle
(Morris et al., 2004).
Although these studies convincingly
showed that the bulge cells as a whole
gave rise to the lower follicle, none
addressed the question of how many
stem cells participate in the formation
of the new anagen follicle or at what
point bulge cells or their progeny are
committed to specific lineages (Kami-
mura et al., 1997; Ghazizadeh and
Taichman, 2001; Kopan et al., 2002).
Several studies have examined lineage
within the follicle using reconstitution
assays in which isolated keratinocytes
are combined with neonatal dermal
cells and grafted onto nude mouse skin
(Weinberg et al., 1993). The mixture
then forms hair follicles. By using a
combination of keratinocytes labeled
with a retrovirus encoding alkaline
phosphatase plus nonlabeled keratino-
cytes for the epithelial component of
the assay, then examining the propor-
tion of labeled cells within the follicle,
an indication of the number of clones
within a follicle can be inferred (Kami-
mura et al., 1997; Topley et al., 1999).
Dotto and co-workers suggested that
the majority of reconstituted follicles
arose from three different clone types:
one each for the ORS, inner root sheath
and hair shaft. Other combinations
were also present, including some
follicles with partial labeling within
one of the layers. Only rarely were
entire follicles labeled indicating that
they may have arisen from single cells.
The limitations of the reconstitution
studies include the manipulation of
the cells required for the reconstitution
of the follicle, which may lead to
‘‘reprogramming’’ events; the resulting
follicles lack normal orientation and
often grow at right angles to each other
– this limits the ability to accurately
orient the follicles in tissue sections and
makes analysis of clones difficult; the
growth cycle of the follicles is not
synchronized making the evaluation
of the hair cycle almost impossible.
This especially limits evaluation of the
bulge, which is most evident during
telogen. Lastly, silencing of the reporter
construct or its inadequate expression
in follicle subpopulations may compli-
cate matters as well.
Kopan and et al. (2002), using
different strategies involving chimeric
mice, presented evidence for approxi-
mately four different clones within a
follicle, but each with the ability to
generate all follicular epithelial cell
types. These chimeric studies were also
limited by manipulation during embry-
ogenesis. Related studies by the same
group looked at X-inactivation in adult
mice, and the findings support the
concept that hair follicle stem cells
are multipotent, but these studies were
limited by the use of vibrissa follicles
during the neonatal time period. An-
other recent study, examining Cre mice
exhibiting recombination events of low
frequency within their cells, also re-
cognized several different types of
clones responsible for different follicle
layers (Legue and Nicolas, 2005). None
of these three studies assessed clones
within the bulge during telogen, thus
the question of how many and which
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bulge cells participate in hair follicle
formation at anagen onset remains
unanswered.
Ultimately, formal lineage analysis,
perhaps using techniques as in the
brain (Zong et al., 2005), will be
needed to elucidate the exact contribu-
tion of individual bulge cells to the
different lineages within the follicle.
Questions remaining include: At what
point, if any, are stem cells ‘‘set aside’’
during development? When are hair
follicle lineages established? That is,
are individual bulge cells committed to
a specific lineage or is each bulge cell
multipotent? How many bulge cells are
required to generate a new lower
anagen follicle, and is the number
different based on the size and type of
follicle? The answers may be important
for designing cell-based treatments for
alopecia (Stenn and Cotsarelis, 2005).
Plasticity of bulge cells?
Intriguing results suggest that cells
isolated from the mouse hair follicle
bulge area have the potential to differ-
entiate into multiple different none-
pithelial tissues, including Schwann
cells and neurons (Amoh et al.,
2005a, b). These cells were isolated
from nestin-eGFP transgenic mice (Li
et al., 2003). Nestin is a neural stem
cell marker. The exact origin of the
nestin positive cells, and whether they
represent a single or mixed population
of cells, needs to be addressed. As
nestin was not differentially expressed
in mouse or human bulge cells (Morris
et al., 1986; Tumbar et al., 2004;
Ohyama et al., 2006), it is unlikely that
these cells represent keratinocytes.
However, regardless of their origin,
nestin positive cells from the skin
possess remarkable regenerative cap-
abilities when used in a nerve injury
model (Amoh et al., 2005a). Similar in
vitro plasticity findings using cells
isolated from human follicles were also
reported (Yu et al., 2006); thus, the
follicle could serve as a source of cells
for a variety of tissue engineering
applications in the future.
Bulge cells: the ultimate cutaneous
epithelial stem cells?
In addition to the role of the bulge cells
in the formation of the hair follicle at
anagen onset, there is a question of
whether bulge cells are necessary for
the homeostasis of the epidermis and
sebaceous gland. One view is that
bulge cells continuously provide pro-
geny that repopulate these tissues
(Lavker and Sun, 2000; Taylor et al.,
2000). If true, then ablation of the bulge
should lead to failure of epidermal
renewal. Recent experiments show that
loss of bulge cells does not lead to loss
of the epidermis, suggesting that the
epidermis possesses stem cells capable
of renewing itself for long periods (Ito
et al., 2005). Other studies have shown
long-term persistence of clones within
the epidermis. These studies utilized
reconstitution assays (Kamimura et al.,
1997; Ghazizadeh and Taichman,
2001). Some evidence was provided
that hair follicle derived cells did move
into the epidermis, especially adjacent
to the hair follicle, but it was not clear
that these cells were bulge derived.
Morris et al. (2004) and Tumbar et al.
(2004) did find that bulge cells can
move into the epidermis, but this was
not systematically studied using lineage
analysis. Recent work in which isolated
bulge keratinocytes were injected into
neonatal mice, then followed, showed
that bulge cells contributed to the
epidermis after engrafting, but even-
tually no cells arising from the injected
cells were found in the epidermis
implying lack of movement of bulge
cells to the epidermis (Claudinot et al.,
2005).
Studies directly addressing the ques-
tion of whether and when bulge cell
progeny migrate to the epidermis have
recently been accomplished (Ito et al.,
2005). Using the K15CrePR;R26R
transgenic mouse, bulge cells were
labeled in 3-week-old mice. Mice were
followed for 6 months to determine the
movement of cells derived from the
bulge into the epidermis. At the end of
the experiment, there was no evidence
that bulge derived cells had migrated to
epidermis. These findings were con-
firmed using a different (sonic hedge-
hog) promoter active in the bulge and
lower follicle (Levy et al., 2005). Thus,
under homeostatic conditions, the epi-
dermis alone is responsible for its
continual renewal. These findings are
important for gene therapy since it will
be important to target stem cells within
the epidermis to correct genetic dis-
orders such as epidermolysis bullosa.
Role of bulge cells in wound healing
The contribution of the hair follicle to
healing of the epidermis following
wounding has been appreciated for
decades by investigators working with
mice and rabbits (Argyris, 1976; Taylor
et al., 2000; Tumbar et al., 2004).
Clinicians are also well aware that
keratinocytes emerge from the follicle
to repopulate wounds. However, the
role of the bulge cells in wound healing
has only recently been characterized
(Ito et al., 2005).
Bulge cell progeny migrate to the
epidermis after different types of
wounding. Using the K15CrePR;R26R
transgenic mouse, bulge cells were
labeled in adult mice (Ito et al.,
2005). Excisional wounding with a
4 mm (punch) trephine resulted in the
migration of bulge cell progeny into the
healing epidermis. At least 25% of the
newly formed epidermis originated
from the bulge cells. Bulge cells were
also stimulated to move into the
epidermis following incisional wounds
and after tape stripping, indicating that
bulge cell activation plays a role in
replenishing lost cells from the epider-
mis after wounding. Surprisingly, how-
ever, despite the presence of bulge-
derived cells in the basal layer of the
reepithelialized epidermis, the majority
of the bulge-derived cells did not
persist in the regenerated epidermis.
This suggests that bulge cells and
epidermal stem cells are intrinsically
different in that epidermal-derived cells
seem better suited for establishing long-
term EPUs (Figure 4).
Role of bulge cells in tumorigenesis
Since epithelial stem cells are thought
to have a lifespan at least as long as that
of the organism, they are thought to be
susceptible to multiple genetic ‘‘hits’’,
which cumulatively may result in
tumor formation (Perez-Losada and
Balmain, 2003). A great deal of evi-
dence in the mouse system points to
hair follicles and stem cells as the
origin of many skin tumors (Stenbach,
1980; Morris et al., 1986). Keratinocyte
stem cells appear to be the target of
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cutaneous carcinogens, and since they
are the slowest cycling cells, hair
follicle stem cells also retain carcino-
gens for extended periods and are thus
more susceptible to tumor promotion
(Morris, 2000).
Since human basal cell carcinomas
(BCCs) are slowly growing tumors,
composed of poorly differentiated cells
with the ability to differentiate into
various adnexal structures, it has been
suggested that the cell of origin is a
multipotent stem cell that is slowly
cycling and has a high proliferative
potential (Cotsarelis et al., 1990). There
is considerable evidence that BCCs
may arise from stem cells within the
hair follicle (Hutchin et al., 2005).
BCCs have been shown to express
bcl-2 (Verhaegh et al., 1997), a marker
of the permanent portion of the hair
follicle, including the bulge (Stenn
et al., 1994). Furthermore, the over-
expression of sonic hedgehog (Shh) in
mouse epidermis causes BCC-like
tumors from invaginating hair follicles,
but has little effect on interfollicular
epidermis (Oro et al., 1997), again
suggesting a follicular origin for BCCs
(Adolphe et al., 2004). The Shh signal-
ing pathway, including ptc, is active in
hair follicle morphogenesis during fetal
development (Millar, 2002).
As trichoepitheliomas (TEs), a
benign hair follicle tumor, and BCCs
have a similar clinical and histological
appearance, and may develop con-
currently in some patients, it has been
proposed that these tumors arise from a
common precursor cell type within the
hair follicle (Headington, 1976). Bio-
chemically, both TEs and BCCs express
cytokeratins 5, 6, 14, 17, and 19
(Schirren et al., 1997a, b); a profile
found in the infrainfundibular ORS
cells of the normal hair follicle, in fetal
germinative cells, and in the fetal hair
follicle bulge. In addition, in one study,
13 of 13 TEs and about one-third of
BCCs expressed K15 suggesting they
originate from bulge cells (Jih et al.,
1999). The findings that both sporadic
TEs and BCCs contain mutations of the
patched (ptc) gene (Gailani et al., 1996;
Johnson et al., 1996) provide compel-
ling evidence that these tumors share a
common tumorigenic mechanism and
are linked to the hair follicle. The
normal expression of ptc in the devel-
oping hair follicle and the presence of
ptc mutations in sporadic TEs as well as
both hereditary and sporadic BCCs
suggest that these tumors arise from a
common cell type within the hair
follicle. The examination of TEs, BCCs,
and other hair follicle tumors with
additional markers for hair follicle stem
cells should lead to insights into the
role stem cells play in formation of
these tumors.
Stem cells and alopecia
Alopecias can be classified into cica-
tricial and non-cicatricial types (Olsen
et al., 2003). The localization of hair
follicle stem cells to the bulge area may
explain why some types of inflamma-
tory alopecias cause permanent follicle
loss (such as lichen planopilaris and
discoid lupus erythematosis), while
others (such as alopecia areata) are
reversible (Paus and Cotsarelis, 1999).
In cicatricial alopecias, inflammation
involves the superficial portion of the
follicle, including the bulge area, sug-
gesting that the stem cells necessary for
follicle regeneration are damaged
(Mobini et al., 2005). The inflammatory
injury of alopecia areata, however,
especially in early lesions, involves
the bulbar region of the hair follicle
that is composed of bulge cell progeny
(Whiting, 2003). Because this area is
immediately responsible for hair shaft
production, its destruction leads to hair
loss. However, the bulge area remains
intact, and a new lower anagen follicle
and subsequent hair shaft can be
produced. Even patients with alopecia
areata for many years can regrow their
hair either spontaneously or in
response to immunomodulation.
The bulge may actually be targeted
by inflammation in androgenetic
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Figure 4. Model for relationship between epidermal and hair follicle stem cells during homeostasis and
after wounding. (a) During normal conditions, epidermal renewal is dependent on cell proliferation
within EPUs, which are clonal populations of cells roughly arranged in hexagonally shaped columns that
produce a single outer squame. Epithelial stem cells in the hair follicle bulge do not contribute to
epidermal renewal. (b) Following full thickness wounding, bulge cells contribute cells to the epidermis
for immediate wound closure (blue upward arrow). Bulge cells also are required for hair follicle cycling
(blue downward arrow) (c). Over time, bulge-derived cells diminish while nonbulge derived cells appear
to predominate in the re-epithelialized wound.
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alopecia (common baldness) as well.
Jaworsky et al. (1992) showed that in
patients with early androgenetic alope-
cia, inflammatory cells localize to the
bulge (Jaworsky et al., 1992). Over
time, this damage could contribute to
the irreversible nature of androgenetic
alopecia as well. The bulge area
appears specifically attacked in early
graft-versus-host disease, which can
cause alopecia (Murphy et al., 1991).
These findings are also consistent
with the idea that the bulge and
lower hair follicle are ‘‘immune privi-
leged’’ since they express low levels
of MHCI.
Bulge cells for tissue engineering
An exciting approach for the use of hair
follicle stem cells in the treatment of
alopecia includes tissue engineering
(Stenn and Cotsarelis, 2005). In one
scenario, isolated hair follicle stem
cells could be used for generating
new follicles in bald scalp. For this to
occur, isolated bulge cells must be
capable of generating new hair folli-
cles. At least two groups have shown
that freshly isolated bulge cells from
adult mice, when combined with neo-
natal dermal cells formed hair follicles
after injection into immunodeficient
mice (Blanpain et al., 2004; Morris
et al., 2004). These studies provided
proof of concept that isolated stem cells
could be a part of tissue-engineering
approaches for treating alopecia.
A goal for treating alopecia with
cell-therapy approaches includes in-
creasing the number of existing folli-
cles, for example, by amplifying
keratinocyte and dermal papilla cell
numbers in vitro prior to transplanta-
tion. Cultured keratinocytes from neo-
natal epidermis have been used for
many years to generate hair follicles in
reconstitution assays. More recently,
freshly isolated bulge cells from adult
mice were shown to form hair follicles
in skin reconstitution assays (Morris
et al., 2004). Importantly, cultured,
individually cloned bulge cells from
adult mice also were shown to form
hair follicles in skin reconstitution
assays (Blanpain et al., 2004). How-
ever, the ratio of new follicles formed
from the number of donor follicles, and
whether non-bulge keratinocytes also
possessed these properties were not
analyzed.
The use of hair follicle stem cells for
tissue engineering approaches will de-
pend on isolation and characterization
of human hair follicle stem cells. A
major advance in this direction was
reported by Ohyama et al. (2006). In
this work, cell surface markers, includ-
ing CD200 and FRIZZLED receptor
were identified on human bulge cells
by using laser capture microdissection
and microarray analysis for gene ex-
pression. A cocktail of antibodies
against cell surface proteins was de-
vised allowing for isolation of living
hair follicle bulge stem cells, thus the
stage is set for isolating human hair
follicle stem cells to address biological
questions relevant to diseases of the
follicle, and eventually for using these
cells for therapeutic purposes.
Molecular profile-stem cell phenotype
Defining the stem cell phenotype at the
molecular level is important for several
reasons. Quiescence is a hallmark of
these cells. Understanding the genes
that distinguish bulge cells from pro-
liferating TA cells, as well as the genes
that convert resting bulge cells to
growing cells, bodes well for gaining
insights into the uncontrolled prolifera-
tion in cancer cells as well as the
precisely orchestrated events of hair
follicle formation at anagen onset. With
the advent of microarrays, large-scale
comparisons of gene expression in
bulge cells versus non-bulge basal
keratinocytes could be performed
(Morris et al., 2004; Tumbar et al.,
2004). These studies, in which bulge
cells were isolated by two very different
techniques, resulted in reassuringly
similar results. At least 60% of the
genes reported as differentially ex-
pressed by the two groups were the
same. Both studies found that genes
involved in activation of the WNT
pathway were generally decreased,
while inhibitors of this pathway were
increased relative to non-bulge basal
keratinocytes. These findings are in line
with studies indicating the importance
of WNT activation for anagen onset
(Millar, 2002; Van Mater et al., 2003).
It is worth noting that large-scale gene
expression studies have been success-
ful in transgenic mice; however, the
relevance of the findings to human hair
and stem cell biology has only recently
been tested (Ohyama et al., 2006).
These investigators found many simila-
rities to the mouse studies, thus validat-
ing the mouse as a useful model for
studying human hair growth. However,
very important differences were also
described (Cotsarelis, 2006). In parti-
cular, CD34, which serves as a mouse
bulge cell marker, is not expressed by
human hair follicle bulge cells (see also
Figure 3). These studies are a major
step in our understanding of human
hair follicle bulge cells.
Regarding genes that may maintain
the stem cell phenotype, functional
studies demonstrate that Rac-1 plays
an important role in the self-renewal of
the epidermis and hair follicle (Benitah
et al., 2005; Dotto and Cotsarelis,
2005). Loss of Rac-1 causes a burst of
proliferation in epidermal keratinocytes
and then synchronized differentiation
and loss of proliferative capability
resulting in thinning of the cutaneous
epithelium. Thus, this gene suppresses
proliferation and differentiation, and
seems important for the switch from
stem cell to TA cell.
The bulge as stem cell niche
Keratinocytes within the bulge area
may depend on their environment or
niche for maintaining their stem cell
characteristics. The bulge area also
houses melanocyte stem cells, which
are normally quiescent but proliferate
at anagen onset to repopulate the new
lower anagen hair follicle with mela-
nocytes that generate melanin leading
to pigmentation of the hair (Nishimura
et al., 2002). Intriguingly, there is
evidence that the follicle, if not the
bulge, serves as a reservoir for imma-
ture Langerhans cells as well as other
immunocytes (Gilliam et al., 1998;
Kumamoto et al., 2003). The role of
the bulge environment in maintaining
cells of different lineages in a relatively
undifferentiated state or instructing
(educating?) immune cells needs
further study.
Summary
The bulge begins as a prominent
structure during human fetal develop-
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ment, but then becomes less obvious;
thus hindering its study. Markers for
bulge cells, such as CD34 expression
and K15 promoter activity, allowed for
the isolation and characterization of
these cells in mouse and human
follicles. Important parallels and differ-
ences between mouse and human
bulge cell gene expression validate
the use of the mouse as a model for
studying human hair follicle stem cells,
but also indicate the need to study
human hair follicles and disease
directly. Propagation of bulge cells
in vitro maintains their stem cell
characteristics; although whether this
is an exclusive property of bulge cells
remains a question. Under normal
homeostatic conditions, epidermal
stem cells and hair follicle stem cells
constitute two distinct populations.
Understanding the differences between
these two types of stem cells, as well as
the signals important for directing
differentiation of these cells into differ-
ent lineages will be important for
developing treatments based on stem
cells as well as clarifying their role in
skin disease.
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